Titration of RCC Tx may be needed for optimum efficacy.
| Publicado en: | Urology Times Vol. 40; no. 6; pp. 30 - 31 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
May2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=75328502&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 75328502 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00939722 URO jtl: Urology Times issn: 00939722 maglogo: N pubinfo: dt: May2012 vid: 40 iid: 6 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 75328502 75328502 108114813 75328502 ppf: 30 ppct: 1 formats: fmt: @attributes: type: P tig: atl: Titration of RCC Tx may be needed for optimum efficacy. aug: au: Kuznar, Wayne sug: subj: Carcinoma, Renal Cell Drug Therapy Survival Imidazoles Administration and Dosage Vascular Endothelial Growth Factors Antagonists and Inhibitors Pharmacokinetics Treatment Duration pubtype: Academic Journal doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|